Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Horizon Pharma
Horizon Pharma
Roche, Horizon lead way for pharma reputation among rare disease patient groups
Roche, Horizon lead way for pharma reputation among rare disease patient groups
Medical Marketing and Media
Roche
Horizon Pharma
reputation
rare disease
Flag link:
Large pharmas probe takeover of Horizon Therapeutics
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Horizon Pharma
M&A
JNJ
Sanofi
Amgen
Flag link:
Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs
Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs
Fierce Pharma
Horizon Pharma
biologics
Ireland
hirings
drug manufacturing
Flag link:
In a quiet year for takeouts, who was buying?
In a quiet year for takeouts, who was buying?
EP Vantage
M&A
Jazz Pharmaceuticals
Horizon Pharma
MorphoSys
Flag link:
Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients
Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients
Fierce Pharma
Horizon Pharma
thyroid eye disease
Tepezza
drug launches
DTC
Flag link:
FDA in-house review spotlights an issue with one of Horizon's endpoints but notes efficacy for lead drug
FDA in-house review spotlights an issue with one of Horizon's endpoints but notes efficacy for lead drug
Endpoints
FDA
Horizon Pharma
clinical trials
teprotumumab
thyroid eye disease
Flag link:
Horizon Pharma’s Thyroid Eye Disease Treatment Could Become a Blockbuster, Analyst Predicts
Horizon Pharma’s Thyroid Eye Disease Treatment Could Become a Blockbuster, Analyst Predicts
BioSpace
Horizon Pharma
thyroid eye disease
teprotumumab
Flag link:
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Concert Pharmaceuticals
Horizon Pharma
Edwards Lifesciences
Zimmer Biomet
Genfit
Precision Biosciences
Boston Scientific
AbbVie
Alexion
Bristol-Myers Squibb
Baxter
Biomarin
AtriCure
Biogen
Seattle Genetics
IPOs
earnings
Flag link:
After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application
After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application
Endpoints
thyroid eye disease
Horizon Pharma
teprotumumab
Flag link:
Genentech, Horizon Earn Spots on List of ‘Companies That Care’
Genentech, Horizon Earn Spots on List of ‘Companies That Care’
BioSpace
Genentech
Horizon Pharma
employees
Flag link:
Horizon Pharma Receives Two Additional Patents on Ravicti
Horizon Pharma Receives Two Additional Patents on Ravicti
CP Wire
Horizon Pharma
Ravicti
Flag link:
Horizon Pharma Receives Two Additional Patents on Ravicti
Horizon Pharma
Ravicti
Flag link:
Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo
Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo
Forbes
physicians
patients
Horizon Pharma
drug pricing
vivmo
Duexis
painkillers
Flag link:
Specialty pharmacy scrutiny hits again with state's focus on Horizon meds
Specialty pharmacy scrutiny hits again with state's focus on Horizon meds
Fierce Pharma
specialty pharmacies
Horizon Pharma
Express Scripts
Valeant Pharmaceuticals
Flag link:
Krystexxa shows signs of life as Horizon keeps pushing sales force expansion
Krystexxa shows signs of life as Horizon keeps pushing sales force expansion
Fierce Pharma
Krystexxa
Horizon Pharma
drug reps
gout
Flag link:
Horizon CEO Tim Walbert knows patients because he is one
Horizon CEO Tim Walbert knows patients because he is one
Medical Marketing and Media
Tim Walbert
Horizon Pharma
Pharma CEOs
autoimmune disease
Duexis
patients
Flag link:
Horizon dives into eye treatments with River Visions acquisition
Horizon dives into eye treatments with River Visions acquisition
BioPharma Dive
Horizon Pharma
River Visions
M&A
eye health
Flag link:
Horizon Pharma buys River Vision and its fast-tracked eye med for $145M
Horizon Pharma buys River Vision and its fast-tracked eye med for $145M
Fierce Biotech
Horizon Pharma
River Vision
eye health
teprotumumab
thyroid eye disease
Flag link:
Tapping into the rare disease market
Tapping into the rare disease market
BioPharma Dive
Rare Diseases
Incyte
Horizon Pharma
Lundbeck
Flag link:
Horizon Pharma - Aggressive Acquirer Makes Another Move
Horizon Pharma - Aggressive Acquirer Makes Another Move
Seeking Alpha
Horizon Pharma
M&A
Flag link:
Pages
1
2
3
4
5
6
next ›
last »